These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33560682)

  • 81. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences.
    Pol S; Haour G; Fontaine H; Dorival C; Petrov-Sanchez V; Bourliere M; Capeau J; Carrieri P; Larrey D; Larsen C; Marcellin P; Pawlostky JM; Nahon P; Zoulim F; Cacoub P; de Ledinghen V; Mathurin P; Negro F; Pageaux GP; Yazdanpanah Y; Wittkop L; Zarski JP; Carrat F;
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1054-1060. PubMed ID: 28994127
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
    Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
    Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Viral hepatitis and hepatocellular carcinoma.
    Sallie R; Di Bisceglie AM
    Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort.
    Gelu-Simeon M; Lewin M; Ostos M; Bayan T; Beso Delgado M; Teicher E; Layese R; Roudot-Thoraval F; Fontaine H; Sobesky R; Salmon-Céron D; Samuel D; Seror O; Nahon P; Meyer L; Duclos-Vallée JC;
    Liver Int; 2019 Jan; 39(1):136-146. PubMed ID: 29947467
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
    Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O
    J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hepatitis B, C and D coinfection in HIV-infected patients: prevalence and progress.
    Ionescu B; Mihăescu G
    Roum Arch Microbiol Immunol; 2011; 70(3):129-33. PubMed ID: 22570927
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.
    Lee HS; Han CJ; Kim CY
    Cancer; 1993 Nov; 72(9):2564-7. PubMed ID: 8402477
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients.
    Mohamed Ael S; al Karawi MA; Mesa GA
    Hepatogastroenterology; 1997; 44(17):1404-6. PubMed ID: 9356863
    [TBL] [Abstract][Full Text] [Related]  

  • 90. HIV and hepatitis C virus: special concerns for patients with cirrhosis.
    Curry MP
    J Infect Dis; 2013 Mar; 207 Suppl 1():S40-4. PubMed ID: 23390304
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011.
    Di Benedetto N; Peralta M; Alvarez E; Schroder MT; Estepo C; Paz S; Fainboim H
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):38-44. PubMed ID: 24378264
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia.
    Dhifallah I; Khedhiri M; Chouikha A; Kharroubi G; Hammami W; Sadraoui A; Azzouz MM; Maamouri N; Khalfallah T; Triki H; Pineau P; Bahri O
    Arch Virol; 2020 Jan; 165(1):33-42. PubMed ID: 31630275
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.
    Baig S; Siddiqui AA; Ahmed WU; Qureshi H; Arif A
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):699-703. PubMed ID: 19889265
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
    Li Q; Li H; Qin Y; Wang PP; Hao X
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 99. HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma.
    Xiao J; Zhang Y; Wu J; -Chen X; Zou W
    AIDS Rev; 2024; 26(1):32-40. PubMed ID: 38530710
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Letter: Rethinking the lower incidence of HCC in HIV-infected patients- A closer look at confounding factors.
    Shao GZ; Zhang W; Wu YF; Fan ZQ; Yang T; Lv GY
    Aliment Pharmacol Ther; 2023 Nov; 58(9):956-957. PubMed ID: 37831527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.